LONDON (Reuters) - GlaxoSmithKline is applying for regulatory approval for the world's first vaccine against malaria, designed for use in children in Africa.
Reuters: Top News, Reuters
Thu, 07/24/2014 - 3:03am
LONDON (Reuters) - GlaxoSmithKline is applying for regulatory approval for the world's first vaccine against malaria, designed for use in children in Africa.